Evidence map›Paper›PMID 32777786›Full record

ArticleInternational archives of allergy and immunology2020

Plasma P-Selectin Is Inversely Associated with Lung Function and Corticosteroid Responsiveness in Asthma.

Mats W Johansson, Brandon M Grill, Karina T Barretto, Molly C Favour, Hazel M Schira, Calvin M Swanson, Kristine E Lee, Ronald L Sorkness, Deane F Mosher, Loren C Denlinger and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in International archives of allergy and immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review.International journal of molecular sciences · 2021
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mats W JohanssonDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA, mwjohansson@wisc.edu.
Brandon M GrillDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Karina T BarrettoDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Molly C FavourDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Hazel M SchiraDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Calvin M SwansonDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Kristine E LeeDepartment of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, USA.
Ronald L SorknessSchool of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
Deane F MosherDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Loren C DenlingerDepartment of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Nizar N JarjourDepartment of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
University of Wisconsin–Madison · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Stability of Severe Asthma Phenotypes: Impact of ExacerbationsU10HL109168 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N · 2011 to 2016
$3.9M
NCATS NIH HHS UL1 TR002373NCRR NIH HHS UL1 RR025011NHLBI NIH HHS U10 HL109168
6 · The paper itself

Abstract

backgroundSevere asthma has multiple phenotypes for which biomarkers are still being defined. Plasma P-selectin reports endothelial and/or platelet activation.

objectiveTo determine if P-selectin is associated with features of asthma in a longitudinal study.

methodsPlasmas from 70 adult patients enrolled in the Severe Asthma Research Program (SARP) III at the University of Wisconsin-Madison were analyzed for concentration of P-selectin at several points over the course of 3 years, namely, at baseline (BPS), after intramuscular triamcinolone acetonide (TA) injection, and at 36 months after baseline. Thirty-four participants also came in during acute exacerbation and 6 weeks after exacerbation.

resultsBPS correlated inversely with forced expiratory volume in 1 s (FEV1) and with residual volume/total lung capacity, an indicator of air trapping. BPS was inversely associated with FEV1 change after TA, by regression analysis. FEV1 did not change significantly after TA if BPS was above the median, whereas patients with BPS below the median had significantly increased FEV1 after TA. BPS was higher in and predicted assignment to SARP phenotype cluster 5 ("severe fixed-airflow asthma"). P-selectin was modestly but significantly increased at exacerbation but returned to baseline within 3 years.

conclusionsHigh BPS is associated with airway obstruction, air trapping, the "severe fixed-airflow" cluster, and lack of FEV1 improvement in response to TA injection. P-selectin concentration, which is a stable trait with only modest elevation during exacerbation, may be a useful biomarker for a severe asthma pheno- or endotype characterized by low pulmonary function and lack of corticosteroid responsiveness.

Indexed as

Adrenal Cortex HormonesAdultAnti-Asthmatic AgentsAsthmaBiomarkers, PharmacologicalDisease ProgressionFemaleFollow-Up StudiesForced Expiratory VolumeHumansLungMaleMiddle AgedPhenotypePlatelet ActivationP-SelectinAdrenal Cortex HormonesAnti-Asthmatic AgentsBiomarkers, PharmacologicalP-SelectinAsthmaCorticosteroidExacerbationLung functionPhenotypeP-selectin

Identifiers

PMID32777786
PMCPMC7609594
OpenAlexW3048663946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.